Welcome Prolytix
We are excited to welcome new Bio Nebraska member, Prolytix.
Novartis Pluvicto™ approved by FDA
Novartis, a member of Bio Nebraska, announced that the FDA approved Pluvicto, a targeted radioligand therapy (RLT) for eligible patients with metastatic castration-resistant prostate cancer. Pluvicto is expected to be available to physicians and patients within weeks.
Bio Nebraska members are saving with Fisher Scientific Purchasing Program
Last year, Bio Nebraska members enrolled in the program saved over $4.5 million, nearly a 50 percent discount off of the list price for laboratory supplies, equipment, chemical, and reagents.
Member Spotlight: Precision Syringe
For our April Member Spotlight, we talked to Adrian Blake, CEO of Precision Syringe, a company set up to commercialize the Suh Precision Syringe, invented by a team from the University of Nebraska Medical Center and led by Dr. Donny Suh.
SCC planning $42M facility to expand science, technology education
Southeast Community College, a member of Bio Nebraska, is planning $42.7 million for facilities dedicated to career training in science and technology. Article by Chris Dunker, Lincoln Journal Star.
UMR Reports 2021 NIH Funding Impact on Nebraska
In Nebraska, the report finds that NIH awarded $136.9 million in grants and contracts during the 2021 fiscal year that directly supported 2,438 jobs and $346 million of economic activity.
U.S. News ranks UNMC educational programs among best
The University of Nebraska Medical Center, a member of Bio Nebraska, received high rankings in the U.S. News & World Report 2023 Best Graduate Schools rankings released this week.
Bio Nebraska Executive Director featured in Make A Move Podcast
Rob Owen, Bio Nebraska’s Executive Director, is featured in the latest Make A Move Podcast episode where he talks about the work Bio Nebraska is doing to support the biosciences in Nebraska.
Viridis Chemical Announces First Production of Renewable Ethyl Acetate
Viridis Chemical, a member of Bio Nebraska, announced its first production of renewable Ethyl Acetate from its manufacturing plant in Columbus, Nebraska.
UNMC, Nebraska Medicine economic impact tops $5.9 billion
The University of Nebraska Medical Center, a member of Bio Nebraska, and its primary clinical partner, Nebraska Medicine, continue to expand their contribution to the state’s economy, according to a recent independent analysis.